TeselaGen is building a rapid prototyping system for fast bio-based construction of sustainably sourced chemicals, therapeutic medicines, and novel vaccines. Their customers are biopharmaceutical and bioindustrial companies like Amgen and Genomatica. Their bioCAD/CAM system is based on technology exclusively licensed from Lawrence Berkeley National Lab and is being beta tested by hundreds of users.
Some data provided by Crunchbase
EquityZen does not have an affiliation with, formal relationship with, or endorsement from TeselaGen or any companies featured above.
This profile is based on publicly available information and is intended to be informative in nature.
To learn more about whether you're eligible, typical investment size, company valuation, and share price, request access here.